In particular, miR-148b has been reported to be down-regulated in NSCLC and associated with poor survival [19] and it may function as a tumour suppressor in NSCLC by targeting carcinoembryonic antigen (CEA) [18]. The gene discussed is CEACAM5; the disease is neoplasm.